article · Annales Africaines de Medecine
Context and objective. Re-hospitalized acute heart failure (AHF) patients' in-hospital mortality and associated factors are unclear. This study aimed to determine prognostic factors and outcomes in these patients. Methods. A retrospective cohort study (January 2021 - October 2024) was conducted at the Centre Hospitalier Sud Francilien. Re-hospitalized AHF patients were analyzed for key data. Cox regression identified mortality predictors. Results. A total of 182 patients (mean age 77.6±11.7 years; 121 (66.5%) male) were included. In-hospital mortality was 41.2%, with a median survival of 9 days. Hypertension (59.9%) and diabetes (44.5%) were the most common cardiovascular risk factors (CVRF). Atrial fibrillation (60.4%) was the main comorbidity. Independent mortality predictors included hypertension (HRa=3.76; p=0.001), cancer (HRa=2.84; p=0.014), chronic obstructive pulmonary disease (HRa=2.50; p=0.020), transition to intensive care unit (HRa=3.32; p=0.006), NT-proBNP ≥10,000 pg/mL (HRa=2.02; p=0.008), high-sensitivity C-reactive protein ≥6 mg/dL (HRa=2.25; p=0.018), and cardiogenic shock (HRa=2.36; p=0.005). Conclusion. Re-hospitalized AHF patients face a high early mortality. Factors such as specific CVRF, comorbidities, and hemodynamic instability, as well as elevated biomarkers of ventricular wall stress and systemic inflammation are key determinants of in-hospital mortality for these patients. These findings underscore the importance of early risk stratification and individualized care. Received: April 1st, 2025 Accepted: May 28th, 2025 https://dx.doi.org/10.4314/aamed.v18i4.2
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4314/aamed.v18i4.2
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.